New integration will consolidate patient data and improve RPM and CCM capabilities for people living with diabetes.
March 22, 2023 – San Francisco, CA GenieMD, Inc. (“GenieMD”), a leader in virtual care platform and services, recognized by Frost and Sullivan as the Innovation leader in North America’s virtual care market, announced today they have completed the integration of the Dexcom APIs (version 3). Dexcom (Nasdaq: DXCM), is the global leader in real-time continuous glucose monitoring (CGM) technology. This effort supports the data integration of the recently announced Dexcom G7 as well as the Dexcom G6 and Dexcom G5 devices.
Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This effort enables the integration of data from Dexcom CGMs into GenieMD’s virtual care platform, making it easy for people using the wearable device to benefit from GenieMD’s platform and services.
As more patients than ever are being diagnosed with diabetes and other related chronic conditions, access to the most up-to-date patient data is critical to offer transformative delivery of care programs, such as Remote Patient Monitoring (RPM) and Chronic Care Management (CCM). When this data is integrated directly into the clinical workflow, the clinical care teams can better support the patient’s journey along the awareness to wellness continuum.
"Nearly two million people use a continuous glucose monitor today, and the ability to capture that data in GenieMD’s platform expands the ability to enhance the quality of care and encourage a patient’s ability to achieve a greater state of wellness” said Dr. Soheil Saadat, Founder and CEO of GenieMD.
An estimated 463 million adults worldwide1 have diabetes. Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin.
GenieMD is an award-winning, global provider of virtual care solutions, inclusive of: Telehealth, Remote Patient Monitoring (RPM), Remote Therapeutic Monitoring (RTM), and Chronic Care Management (CCM) coupled with access to medical experts on a 24/7 basis. GenieMD offers customized, white-labeled virtual care solutions to hospitals, health systems, large group practices, commercial insurance carriers, schools, and self-insured employers. GenieMD clients are based throughout the United States and the world. Maximizing the power of cloud computing, big data, artificial intelligence, and mobile technologies, GenieMD is transforming healthcare by providing a seamless and continuous care model to patients when they need it the most.GenieMD’s mission is to democratize healthcare globally and help all patients get better faster. For more information visit www.genieMD.com or contact bizdev@genieMD.com.